| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Rosemary Turner is Director at MUSA. Rosemary Turner's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $229K at current prices.
The MUSA filings lean toward selling, a net 1,968 shares.
Rosemary Turner has 24 Form 4 filings on record from October 2021 to August 2026, all as Director at Murphy USA (MUSA), 2021–2026.
The 50 reported transactions were 39 option or other derivative awards, 6 option exercises, 4 open-market sales and 1 disposition back to the company.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $1.0M.
The largest open-market sale was 966 shares of MUSA at an average $571.88 on August 20, 2026, about $552K.
None of the 3 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.